H-VTV-OH

Ref. 3D-PP49333

Informations sur le produit

• Nom: H-VTV-OH

Description

Peptide H-VTV-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-VTV-OH include the following: Secretory production of a camelid single-domain antibody (VHH, nanobody) by the Serratia marcescens Lip system in Escherichia coli T Asada, D Takagi, M Nakai, S Abe, K Yuasa - and Biophysical Research , 2021 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0006291X2100317X Silencing of small valosin-containing protein-interacting protein (SVIP) reduces very low density lipoprotein (VLDL) secretion from rat hepatocytes by disrupting its S Tiwari, S Siddiqi, O Zhelyabovska - Journal of Biological , 2016 - ASBMBhttps://www.jbc.org/article/S0021-9258(20)40894-4/abstract Identification Of Proteins Regulating Vldl Sorting Into The Vldl Transport Vesicle (vtv) And Involved In The Biogenesis Of The Vtv S Tiwari - 2013 - stars.library.ucf.eduhttps://stars.library.ucf.edu/etd/3006/ The identification of the SNARE complex required for the fusion of VLDL-transport vesicle with hepatic cis-Golgi S Siddiqi, AM Mani , SA Siddiqi - Biochemical Journal, 2010 - portlandpress.comhttps://portlandpress.com/biochemj/article-abstract/429/2/391/45297 Evaluation the Reactivity of a Peptide-Based Monoclonal Antibody with Drug Resistant Pulsotypes of Acinetobacter Baumannii as Potential Therapeutic Approach O Yeganeh , M Shabani , P Pakzad, N Mosaffa - 2021 - researchsquare.comhttps://www.researchsquare.com/article/rs-1010382/latest The high identity of the Trypanosoma cruzi Group-I of trans-sialidases points them as promising vaccine immunogens MF Pacini, A Perdomini, C Bulfoni Balbi - Proteins: Structure , 2023 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/prot.26537 Epitope Mapping of Immunogenic and Adhesive Structures in Repetitive Domains of Mycoplasma bovis Variable Surface Lipoproteins K Sachse , JH Helbig, I Lysnyansky - Infection and , 2000 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/iai.68.2.680-687.2000 Beyond topline results for the oral (non-peptide) GLP-1R agonist TTP273 in type 2 diabetes: how much and when JLR Freeman, IM Dunn - Diabetol. Conf. 53rd Annu , 2017 - vtvtherapeutics.comhttps://vtvtherapeutics.com/wp-content/uploads/pdf/ttp273-201_presentation-112-easd-2017_v3.pdf Estimation and prediction of the air-water interfacial tension in conventional and peptide surface-active agents by random Forest regression F Ricardo, P Ruiz-Puentes , LH Reyes , JC Cruz - Chemical Engineering , 2023 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0009250922007928 Proteomic analysis of the very low density lipoprotein (VLDL) transport vesicles A Rahim , E Nafi-valencia, S Siddiqi, R Basha - Journal of , 2012 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S1874391912000668

• Marque: Biosynth